166 related articles for article (PubMed ID: 1702493)
21. [Bronchial arterial infusion chemotherapy (BAI) and BAI with radiotherapy in advanced non-small cell lung cancer].
Sato T; Mitsuhata N; Fujiwara K; Miyake M; Jyojya I; Ono T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):719-22. PubMed ID: 2451474
[No Abstract] [Full Text] [Related]
22. Induction chemotherapy for T4 centrally located non-small cell lung cancer.
Rendina EA; Venuta F; De Giacomo T; Ciccone AM; Ruvolo G; Coloni GF; Ricci C
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):225-33. PubMed ID: 9918961
[TBL] [Abstract][Full Text] [Related]
23. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Segawa Y; Kiura K; Takigawa N; Kamei H; Harita S; Hiraki S; Watanabe Y; Sugimoto K; Shibayama T; Yonei T; Ueoka H; Takemoto M; Kanazawa S; Takata I; Nogami N; Hotta K; Hiraki A; Tabata M; Matsuo K; Tanimoto M
J Clin Oncol; 2010 Jul; 28(20):3299-306. PubMed ID: 20530281
[TBL] [Abstract][Full Text] [Related]
24. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
Nishiwaki Y; Nagai K; Kodama T; Nishiyama H; Hojo H; Matsumoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():203-11. PubMed ID: 8007467
[TBL] [Abstract][Full Text] [Related]
25. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
[TBL] [Abstract][Full Text] [Related]
27. A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.
Shinkai T; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Kojima A; Oshita F; Saijo N
Eur J Cancer; 1991; 27(5):571-5. PubMed ID: 1647183
[TBL] [Abstract][Full Text] [Related]
28. Surgical adjuvant chemotherapy in non-small cell lung cancer.
Holmes EC
Semin Oncol; 1988 Jun; 15(3):255-60. PubMed ID: 2837830
[TBL] [Abstract][Full Text] [Related]
29. Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
Murray N; Coppin C; Coldman A; Pater J; Rapp E
J Clin Oncol; 1994 Nov; 12(11):2333-9. PubMed ID: 7964949
[TBL] [Abstract][Full Text] [Related]
30. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
Fujii M; Kiura K; Okabe K; Toki H; Kimura M
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
[TBL] [Abstract][Full Text] [Related]
31. Intermittent adjuvant chemo-immunotherapy after resection of non-small cell lung cancer with multilevel mediastinal lymph node metastasis.
Suzuki M; Kimura H; Iwai N; Fujisawa T
Oncol Rep; 2000; 7(3):545-9. PubMed ID: 10767366
[TBL] [Abstract][Full Text] [Related]
32. Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
Vansteenkiste JF; De Leyn PR; Deneffe GJ; Lievens YN; Nackaerts KL; Van Raemdonck DE; van der Schueren E; Lerut TE; Demedts MG
Ann Oncol; 1998 Mar; 9(3):261-7. PubMed ID: 9602259
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center.
Joss RA; Bürki K; Dalquen P; Schatzmann E; Leyvraz S; Cavalli F; Ludwig C; Siegenthaler P; Alberto P; Stahel R
Cancer; 1990 Jun; 65(11):2426-34. PubMed ID: 2159837
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study.
Niiranen A; Niitamo-Korhonen S; Kouri M; Assendelft A; Mattson K; Pyrhönen S
J Clin Oncol; 1992 Dec; 10(12):1927-32. PubMed ID: 1333518
[TBL] [Abstract][Full Text] [Related]
35. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
Mouillet G; Monnet E; Milleron B; Puyraveau M; Quoix E; David P; Ducoloné A; Molinier O; Zalcman G; Depierre A; Westeel V;
J Thorac Oncol; 2012 May; 7(5):841-9. PubMed ID: 22722786
[TBL] [Abstract][Full Text] [Related]
36. A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
Rosell R; Maestre J; Font A; Moreno I; Molina F; Milla A; Gómez-Codina J; Camps C
Semin Oncol; 1994 Jun; 21(3 Suppl 4):28-33. PubMed ID: 8209274
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).
Dautzenberg B; Chastang C; Arriagada R; Le Chevalier T; Belpomme D; Hurdebourcq M; Lebeau B; Fabre C; Charvolin P; Guérin RA
Cancer; 1995 Sep; 76(5):779-86. PubMed ID: 8625180
[TBL] [Abstract][Full Text] [Related]
38. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Nakagawa H; Imamura F; Minamigawa K; Kobayashi H
Oncol Rep; 2001; 8(2):279-83. PubMed ID: 11182040
[TBL] [Abstract][Full Text] [Related]
40. Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer.
Oshita F; Nishio K; Kameda Y; Mitsuda A; Ikehara M; Tanaka G; Yamada K; Nomura I; Noda K; Arai H; Ito H; Nakayama H
Oncol Rep; 2000; 7(6):1225-8. PubMed ID: 11032919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
